NEW YORK (Reuters Health) – Long-term treatment with clofazimine or nitroimidazoles may help control Crohn’s disease, according to the authors of a systematic review and meta-analysis. Several bacteria…
NEW YORK (Reuters Health) – In women over 55, simple ovarian cysts are common, usually resolving or persisting without progression, according to data from the prospective Prostate, Lung,…
NEW YORK (Reuters Health) – A single negative whole-leg compression ultrasound (CUS) can effectively rule out deep vein thrombosis (DVT) in many patients, according to a meta-analysis in…
NEW YORK (Reuters Health) – In patients with schizophrenia, clozapine does not seem to increase the risk of cardiovascular death relative to risperidone, despite known differences in cardiometabolic…
NEW YORK (Reuters Health) – Whether clopidogrel is abruptly stopped or slowly tapered, there is no evidence of a rebound in platelet activity, German researchers report. They point…
NEW YORK (Reuters Health) – Sonographic surveillance of newborns with mild hip dysplasia can reduce the need for early abduction splinting without increasing the risk of persistent or…
NEW YORK (Reuters Health) – Stimulant medications show greater efficacy than nonstimulants for treating attention-deficit/hyperactivity disorder (ADHD) in adults, according to a new meta-analysis. Study authors Dr. Stephen…
NEW YORK (Reuters Health) – In patients with Barrett’s esophagus, radiofrequency ablation (RFA) before or after anti-reflux surgery can reduce metaplasia and dysplasia, but whether the multi-treatment approach…
NEW YORK (Reuters Health) – Performing coronary artery bypass graft (CABG) surgery in high-risk patients without placing them on cardiopulmonary bypass does not increase their risk of short-term…
NEW YORK (Reuters Health) – For hepatocellular carcinomas (HCC) larger than 2 cm, radiofrequency ablation (RFA) is the best ablative therapy, a meta-analysis shows – but for smaller…
NEW YORK (Reuters Health) – Adding trastuzumab (Herceptin) to standard chemotherapy can significantly improve event-free survival in women with HER2-positive locally advanced or inflammatory breast cancer, according to…
NEW YORK (Reuters Health) – L-carnitine supplements can improve liver function, liver histology and other manifestations of nonalcoholic steatohepatitis (NASH), Italian researchers say. “L-carnitine supplementation induces regression of…
